Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving …
regarded as being in the early stages of a progressive neurodegenerative disease involving …
Idiopathic REM sleep behaviour disorder and neurodegeneration—an update
So-called idiopathic rapid eye movement (REM) sleep behaviour disorder (RBD), formerly
seen as a rare parasomnia, is now recognized as the prodromal stage of an α …
seen as a rare parasomnia, is now recognized as the prodromal stage of an α …
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson's
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
I Poggiolini, V Gupta, M Lawton, S Lee, A El-Turabi… - Brain, 2022 - academic.oup.com
Several studies have confirmed the α-synuclein real-time quaking-induced conversion (RT-
QuIC) assay to have high sensitivity and specificity for Parkinson's disease. However …
QuIC) assay to have high sensitivity and specificity for Parkinson's disease. However …
[HTML][HTML] Clinical and imaging evidence of brain-first and body-first Parkinson's disease
J Horsager, K Knudsen, M Sommerauer - Neurobiology of disease, 2022 - Elsevier
Braak's hypothesis has been extremely influential over the last two decades. However,
neuropathological and clinical evidence suggest that the model does not conform to all …
neuropathological and clinical evidence suggest that the model does not conform to all …
Quality of life in Parkinson's disease: A systematic review and meta‐analysis of comparative studies
N Zhao, Y Yang, L Zhang, Q Zhang… - CNS neuroscience & …, 2021 - Wiley Online Library
Background Studies regarding the impact of Parkinson's disease (PD) on quality of life
(QOL) have reported conflicting results, and the underlying QOL domains require further …
(QOL) have reported conflicting results, and the underlying QOL domains require further …
The α-synuclein origin and connectome model (SOC Model) of Parkinson's disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline
P Borghammer - Journal of Parkinson's disease, 2021 - content.iospress.com
A new model of Parkinson's disease (PD) pathogenesis is proposed, the α-Synuclein Origin
site and Connectome (SOC) model, incorporating two aspects of α-synuclein pathobiology …
site and Connectome (SOC) model, incorporating two aspects of α-synuclein pathobiology …
GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches
GM Riboldi, AB Di Fonzo - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is the second most common degenerative disorder. Although the
disease was described more than 200 years ago, its pathogenetic mechanisms have not yet …
disease was described more than 200 years ago, its pathogenetic mechanisms have not yet …
International consensus statement on allergy and rhinology: olfaction
Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …
The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies
Several studies report an association between REM Sleep Behavior Disorder (RBD) and
neurodegenerative diseases, in particular synucleinopathies. Interestingly, the onset of RBD …
neurodegenerative diseases, in particular synucleinopathies. Interestingly, the onset of RBD …